Prices re-read October 15, 2026Methodology v4.1How we score →
Compare Providers
Home / Compare / Enhance.MD vs Found
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Released: ·Last reviewed: ·Prices re-read October 15, 2026 (rows marked)·Methodology v4.1

Researched By
Medical Researcher · Western University of Health Sciences
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Enhance.MD vs Found: pricing, doses and services compared

Which is better for whom?

Enhance.MD and Found serve different priorities. Enhance.MD: Flat pricing at every dose, with a dedicated microdose tirzepatide programme at… Found: Found includes compounded medication and membership in one price, billed per 28-day… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Prices marked October 15, 2026 were re-read that day; other fields are from the July 12, 2026 review.

How do they compare, field by field?

Enhance.MD vs Found — side by side; July 12, 2026 figures, with October 15, 2026 re-reads marked
FactorEnhance.MDFound
Starting price$169/mo microdose tirzepatide; $212 semaglutide, read Oct 15 Verified Oct 15$239 per 28 days (12-month plan), read Oct 15 Re-read Oct 15 · changed
Renewal price$280 tirzepatide (12-month); $329 month to month Verified Oct 15$359 month to month; $289 on 6 months Re-read Oct 15 · changed
Highest-dose priceFlat at all doses Reported — pending verificationFlat across all compounded GLP-1s and all doses Reported — pending verification
Membership$0 Reported — pending verificationNone — medication now included Reported — pending verification
LabsLab testing included Reported — pending verificationFree insurance check Reported — pending verification
ShippingFree Reported — pending verificationIncluded Reported — pending verification
Commitment12-month for best rate Reported — pending verification12-month prepay for the headline rate Reported — pending verification
PharmacyNot independently verified Reported — pending verificationNot independently verified Reported — pending verification
ClinicianProvider care included Reported — pending verificationClinician network + behavioural coaching Reported — pending verification
StatesPending research Reported — pending verificationPending research Reported — pending verification

Which one wins on each decision factor?

Each factor below is measured from the providers’ own pages read on October 15, 2026, and the numbers are shown so you can check them. Where one program wins every factor, it is because the other printed a higher price or no price at all; the limitations sections above still apply.

Winner by decision factor, from prices and pages read October 15, 2026
Decision factorBetter fit
Lower standing monthly price (lowest plan, Oct 15)Found ($239 vs $280)
Lower month-to-month price (Oct 15)Enhance.MD ($329 vs $359)
Names its dispensing pharmacy on its pagesNeither
States the same price at every doseEnhance.MD

Enhance.MD: who it fits

Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12 weeks). Standard tirzepatide is $280 and semaglutide $212 on the 12-month plan. Limitation: Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026. Full Enhance.MD review →

Found: who it fits

Found includes compounded medication and membership in one price, billed per 28-day cycle. On October 15, 2026 its compounded tirzepatide was $359 month to month, $309 on 3 months, $289 on 6 and $239 on 12, with $219 for the first month. The old $249-medication-plus-$99-membership split is retired. Limitation: Its lowest price needs a 12-month plan, and 28-day billing means 13 charges a year. Found also resells brand Mounjaro and Ozempic at roughly $1,100–$1,199/month — near-retail, when the manufacturers sell them direct for far less. Full Found review →

Frequently asked questions

Is Enhance.MD or Found cheaper?

On starting price: Enhance.MD is $169/mo microdose tirzepatide; $212 semaglutide, read Oct 15 and Found is $239 per 28 days (12-month plan), read Oct 15. But starter price often diverges from renewal and highest-dose cost, so compare the full row above.

How were these figures verified?

Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.

Sources

  1. Both providers' pricing and terms pages, captured July 12, 2026.
  2. Our price-normalization methodology.
  3. CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.